Publikace
- Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?2019 | 2. lékařská fakulta
- Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells2017 | 2. lékařská fakulta
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | 2. lékařská fakulta
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | 2. lékařská fakulta, 1. lékařská fakulta, 3. lékařská fakulta
- Methods to assess DC-dependent priming of T cell responses by dying cells2020 | 2. lékařská fakulta
- Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms2020 | 2. lékařská fakulta
- Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?2019 | 2. lékařská fakulta
- Radiotherapy in Combination With Cytokine Treatment2019 | 2. lékařská fakulta
- Vzájemná kooperace mezi imunitními buňkami při vzniku a prevenci diabetu 1. typu +12019 | 2. lékařská fakulta
- Induction of tolerance and immunity by dendritic cells: Mechanisms and clinical applications2019 | 2. lékařská fakulta
Loading network view...